17.28USD+1.17%Mkt Cap: 765.92M USDP/E: —Last update: 2026-06-01
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to iden…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap765.92M USD
Enterprise Value389.43M USD
Revenue (TTM)10.32M USD
Gross Profit-72.95M USD
Net Income (TTM)-80.61M USD
Revenue/Share0.2740 USD
Last Price17.28 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees60
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.01
PEG—
EV/EBITDA-3.84
EV/Revenue37.75
P/S74.50
P/B2.02
EPS (TTM)-2.40
EPS (Forward)-2.16
52W Range
3.88067% of range24.00
52W High24.00 USD
52W Low3.880 USD
Profitability
Gross Margin0.00%
Oper. Margin-915.40%
EBITDA Margin0.00%
Profit Margin-896.11%
ROE-29.63%
ROA-27.33%
Growth
Revenue Growth91.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-81.63M USD
CapEx (TTM)719.00K USD
FCF Margin-565.51%
FCF Yield-7.62%
Net Debt-379.16M USD
Net Debt/EBITDA3.74
Balance Sheet
Debt/Equity0.02
Current Ratio24.76
Quick Ratio24.38
Book Value/Sh8.541 USD
Cash/Share8.620 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)49.50 USD
Target Range23.00 USD – 73.00 USD
# Analysts8
Ownership
Shares Out.44.45M
Float33.69M
Insiders2.44%
Institutions85.51%
Short Interest
Short Ratio4.2d
Short % Float4.34%
Short % Out.3.84%
Shares Short1.71M
Short (prev mo.)1.75M
Technical
SMA 5017.44 (-0.9%)
SMA 20013.04 (+32.6%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)396.77K
Avg Vol (10d)487.95K
Technical Indicators
RSI (14)48.9
MACD-0.2820
MACD Signal-0.2661
MACD Hist.-0.0159
BB Upper19.20 USD
BB Middle17.22 USD
BB Lower15.24 USD
BB Width23.02%
ATR (14)1.166 USD
Vol Ratio (20d)0.36x